The pharmaceutical company makes drugs to treat HIV, psoriasis, rheumatiod arthritis, low testosterone, thyroid problems, and Parkinson’s.
Looking for leads, investment insights, or competitive intelligence?
News about AbbVie
A year's course of the blockbuster drug is $60,000, more than triple its initial 2012 price.
The average price increase is nearly three times the current U.S. inflation rate.
AbbVie Inc. won U.S. approval for an oral medicine that treats pain caused by the gynecological disorder endometriosis.
The new cure could be a boon to poorer nations.